Malaria Journal

official impact factor 3.49

Open Access

A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya

Elizabeth A Juma*, Charles O Obonyo, Willis S Akhwale and Bernhards R Ogutu

Malaria Journal 2008, 7:262 doi:10.1186/1475-2875-7-262

Accesses  

  • Last 30 days: 53 accesses
  • Last year: 573 accesses
  • All time: 2828 accesses

Cited by

BioMed Central: 3 citations

Research   Open Access

The use of paediatric artemisinin combinations in sub-Saharan Africa: a snapshot questionnaire survey of health care personnel

Selidji T Agnandji, Florian Kurth, Jose F Fernandes, Solange A Soulanoudjingar, Beatrice P Abossolo, Gyslain Mombo-Ngoma, Arti Basra, Raquel Gonzalez, Gondo Kizito, Pembe I Mayengue, Lorenz Auer-Hackenberg, Saadou Issifou, Bertrand Lell, Ayola A Adegnika, Michael Ramharter Malaria Journal 2011, 10:365 (14 December 2011)

Paper addressing a very important problem within the policy of using ACT treating uncomplicated falciparum malaria in African children.

Research   Open Access Highly Accessed

Changing malaria intervention coverage, transmission and hospitalization in Kenya

Emelda A Okiro, Victor A Alegana, Abdisalan M Noor, Robert W Snow Malaria Journal 2010, 9:285 (15 October 2010)

Description of the changes in malaria epidemiology in Kenya by looking at the changes in malaria admission in eight hospitals and in several explanatory variables, such as ITN coverage. This work brings additional information to the current debate over the “epidemiological transition” of malaria in sub-Saharan Africa.

Review   Open Access

Dispersible formulation of artemether/lumefantrine: specifically developed for infants and young children

Salim Abdulla, Issaka Sagara Malaria Journal 2009, 8(Suppl 1):S7 (12 October 2009)